Ventripoint Diagnostics Ltd.
TSX VENTURE : VPT

Ventripoint Diagnostics Ltd.

October 20, 2015 09:27 ET

Ventripoint Corporate Update

SEATTLE, WASHINGTON--(Marketwired - Oct. 20, 2015) - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Corporation") (TSX VENTURE:VPT) announces that James Bodtke, Vice-president, Clinical Affairs & Development for the Corporation has left the Company. Ventripoint wishes to thank Mr. Bodtke for his service and wishes him well in his future endeavors.

Additional information on Ventripoint is available on SEDAR at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information